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ABSTRACT
The ability of non-pigmented, rapidly growing mycobacteria (NPRGM) to attach to polypropylene
sutures was evaluated using an in-vitro assay. Thirty clinical isolates and five culture collection strains
of NPRGM, together with Staphylococcus epidermidis ATCC 35983, were tested. Mycobacterium fortuitum
and Mycobacterium chelonae showed the highest attachment ability, which differed significantly from the
results obtained with Mycobacterium peregrinum. According to these results, NPRGM are able to attach to
polypropylene sutures, and the species implicated most frequently in human infection showed
increased levels of attachment in comparison with the other mycobacteria studied.
Keywords Attachment, in-vitro assay, Mycobacterium spp., non-pigmented mycobacteria, polypropylene sutures
Original Submission: 5 December 2006; Revised Submission: 16 March 2007; Accepted: 21 April 2007
Clin Microbiol Infect 2007; 13: 902–907
INTRODUCTION
Non-pigmented rapidly growing mycobacteria
(NPRGM) are interesting organisms, not only
because they are isolated frequently in clinical
laboratories, but also because they are well-docu-
mented human pathogens [1–4]. These organisms
produce biofilm in several environmental
settings, including soil and water systems [3,5].
They have also been isolated from other sources,
e.g., ice machines, disinfectants and antibiotic
solutions, all of which have been considered to be
the source of outbreaks and pseudo-outbreaks
caused by these organisms [2,3]. NPRGM are
often described as a cause of nosocomial infec-
tions, especially those involving surgical compli-
cations related to foreign bodies [1,2], e.g.,
surgical site infections [6,7], bacteraemia [8,9],
bone and joint infections [10–12], and prosthetic
valve endocarditis [4,13–15]. The species isolated
most frequently from such infections are Myco-
bacterium fortuitum, Mycobacterium chelonae and
Mycobacterium abscessus, while other members of
this group, e.g., Mycobacterium peregrinum and
Mycobacterium mucogenicum, are found less fre-
quently [1,3,11]. As disease caused by NPRGM is
not subject to compulsory reporting, no data
concerning their actual incidence have been pub-
lished, but these species are isolated frequently in
clinical microbiology laboratories [12], with one-
third of isolates being considered to be clinically
significant [16]. The fact that these organisms
grow in commonly used culture media means
that they can be misidentified as diphtheroids, so
that their actual incidence could be even higher
than that recorded by clinical mycobacteriology
laboratories [14,15].
In the nosocomial setting, NPRGM infections
have been associated frequently with foreign
bodies, e.g., prosthetic heart valves or mamma-
plasty prostheses, as well as numerous surgical
site infections [1–4]. Studies of skin and soft-
tissue infections caused by NPRGM have iden-
tified trauma or previous surgery as risk-factors
in >50% of cases [17,18]. In the Fundacio´n
Jime´nez Dı´az Hospital (Madrid, Spain), eight of
20 documented cases of infection caused by
NPRGM have been associated with foreign
bodies [16].
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Despite broad knowledge of the clinical, diag-
nostic and therapeutic aspects of human
infections caused by NPRGM, only a few in-vitro
studies of the pathogenic mechanisms involved
have been published [19,20]. In particular, there
has been only one previous in-vitro study of the
ability of different species of NPRGM to adhere to
various biomaterials [21], and only two species
were tested. The present study aimed to evaluate
the attachment of a wider range of species of
NPRGM to suture materials used commonly in
surgical procedures.
MATERIALS AND METHODS
Bacterial isolates
Thirty clinical isolates of NPRGM (two M. abscessus, nine
M. chelonae, 11 M. fortuitum, two M. mucogenicum and six
M. peregrinum (Table 1) were studied, together with the
following strains from culture collections: M. fortuitum
ATCC 13756; M. chelonae ATCC 19235; M. peregrinum
ATCC 14467; M. abscessus DSM 44196; and M. mucogenicum
DSM 44124. The glycocalyx-producing Staphylococcus epider-
midis strain ATCC 35983 was used as a control.
Identification of bacterial isolates
All clinical isolates were identified initially by standard
biochemical tests, including nitrate reductase, production of
arylsulphatase, Tween-80 hydrolysis, growth on MacConkey
agar without crystal violet, growth in the presence of NaCl 5%
w ⁄v, use of citrate, mannitol, inositol, sorbitol and rhamnose,
and growth at 30C, 37C and 42C. The tests were performed
according to conventional protocols [22]. Identifications were
confirmed by PCR restriction analysis, as described by Telenti
et al. [23]. Bacteria were then stored in sterile skimmed milk at
)20C until further experiments were performed.
Evaluation of growth rate
Mycobacteria were harvested from growth on Tryptic Soy
Agar containing sheep blood 5% v ⁄v (bioMe´rieux, Marcy
L’Etoile, France) and adjusted to 108 CFU ⁄mL in sterile
phosphate-buffered saline (PBS). This suspension was diluted
to 106 CFU ⁄mL, and 10 lL of this dilution was streaked on
Tryptic Soy Agar containing sheep blood 5% v ⁄v. The
inoculated plates were incubated at 30C for 1 week and
growth of the isolates was recorded daily. The detection of
colonies that were 0.5 mm in diameter was considered to be
the baseline for evaluating the growth rate.
Growth media and incubation conditions
Mycobacterial isolates were grown at 30C on Middlebrook
7H10 agar (Becton Dickinson, Franklin Lakes, NJ, USA)
supplemented with glycerol for 7 days, and were later grown
in Middlebrook 7H9 broth (Becton Dickinson) supplemented
with Tween-80 0.01% v ⁄v for 5 days at 30C. No media changes
were performed during the incubation period. S. epidermidis
ATCC 35983 was grown overnight at 37C on Tryptic Soy Agar
containing sheep blood 5% v ⁄v, and was grown subsequently
in Tryptic Soy Broth (bioMe´rieux) at 37C for 1 day.
Evaluation of attachment
To evaluate bacterial attachment, the protocol described by
Yorganci et al. [24] was modified as follows. Sterile polypro-
pylene monofilament suture (calibre 0) fragments (2 cm long)
(Ethicon Inc., Sommerville, NJ, USA) were immersed sepa-
rately in tubes containing 2.5 mL of PBS (Sigma, St Louis, MO,
USA) and were incubated at 37C for 24 h. The PBS was then
replaced by 2.5 mL of bacterial inoculum, adjusted previously
to a 0.5 · McFarland standard (108 CFU ⁄mL). After incubation
for 30 min at 37C, the inoculum was removed and replaced
by sterile PBS. The tubes were then incubated for 24 h at 37C.
Next, the suture fragments were washed 12 times with sterile
distilled water to remove non-adherent bacteria, placed in
2.5 mL of sterile PBS, and sonicated at low power for 5 min in
a Bandelin Sonorex TK-52 sonicator (Schalltec GmbH, Mo¨r-
felden-Walldorf, Germany). Attached bacteria were quantified
by preparing 1:10 serial dilutions from the sonicate and
streaking 100 lL of each dilution on Middlebrook 7H10 agar
plates. The plates were incubated at 30C for 7 days and the
colonies were then counted. Attachment of S. epidermidis was
quantified by the same procedure, except that the sonicate was
streaked on Tryptic Soy Agar containing sheep blood 5% v ⁄v
and the plates were incubated for 24 h at 37C. All experi-
ments were performed in triplicate and repeated on two to
four occasions.
Table 1. Isolates of non-pigmented rapidly growing
Mycobacterium spp. included in the study
Isolate Species Sample
Clinical
significance
Growth
rate (days)
ATCC 13756 M. fortuitum NA NA 4
ATCC 19235 M. chelonae NA NA 4
FJD-24 M. fortuitum Skin biopsy Yes 4
FJD-26 M. fortuitum Sputum No 4
FJD-36 M. fortuitum Sputum No 5
FJD-37 M. fortuitum Sputum No 4
FJD-53 M. fortuitum Sputum No 5
FJD-55 M. fortuitum Sputum No 4
FJD-56 M. fortuitum Sputum No 4
FJD-58 M. fortuitum Sputum No 4
FJD-61 M. fortuitum Bronchial washing No 4
FJD-65 M. fortuitum Sputum No 5
FJD-69 M. fortuitum Skin biopsy Yes 4
FJD-25 M. chelonae Blood culture Yes 6
FJD-29 M. chelonae Wound exudate Yes 4
FJD-43 M. chelonae Vitreous humour Yes 5
FJD-44 M. chelonae Ascitic fluid No 4
FJD-50 M. chelonae Wound exudate Yes 6
FJD-51 M. chelonae Wound exudate No 5
FJD-83 M. chelonae Pleural biopsy No 5
FJD-40-1 M. chelonae Pleural fluid No 4
FJD-40-2 M. chelonae Pleural fluid No 4
FJD-64 M. abscessus Wound exudate Yes 4
FJD-95 M. abscessus Wound exudate Yes 4
DSM 44196 M. abscessus NA NA 4
FJD-18 M. peregrinum Pericardial fluid No 4
FJD-15 M. peregrinum Blood culture No 4
FJD-20 M. peregrinum Renal biopsy No 4
FJD-72 M. peregrinum Bronchial aspirate No 4
ATCC 14467 M. peregrinum NA NA 4
FJD-213 M. peregrinum Lung biopsy No 4
FJD-223 M. peregrinum Urine No 4
DSM 44124 M. mucogenicum NA NA 5
FJD-155 M. mucogenicum Pleural fluid No 4
FJD-187 M. mucogenicum Blood culture No 4
NA, not applicable.
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Data analysis
The Bartlett test was used to confirm the normal distribu-
tion. The Kruskall–Wallis test was used for statistical
multiple comparisons of the average total bacterial counts.
Paired comparison between two species was performed
using the Mann–Whitney test. In order to compare the
attachment properties and growth rates of the individual
isolates, the total bacterial count data were analysed by
dividing the isolates into two groups (high or low bacterial
count, with a breakpoint of 5 · 105 CFU). The groups were
then compared, according to the day on which growth was
detected for each isolate, using Fisher’s exact test. All
analyses were performed using SPSS v.10.0 (SPSS Inc.,
Chicago, IL, USA).
RESULTS
All species attached to the sutures. The average
total count of attached bacteria was highest for
M. fortuitum and lowest for M. mucogenicum. The
average total counts were: M. fortuitum, 3.5 ·
105 CFU (95% CI, 6.6 · 103 - 6.9 · 105; range,
5 · 102 - 3.6 · 106); M. chelonae, 1.9 · 105 CFU
(95% CI, 2.5 · 104 - 3.5 · 105; range, 2.5 · 103 -
1.2 · 106); M. abscessus, 1.8 · 103 CFU (95% CI, 0 -
3.7 · 103; range, 2.5 · 103 - 6.25 · 103); M. peregri-
num, 1.5 · 103 CFU (95% CI, 4.2 · 102 - 2.5 · 103;
range, 5 · 102 - 7.5 · 103); M. mucogenicum,
1.1 · 103 CFU (95% CI, 8.5 · 102 - 1.3 · 103; range,
2.5 · 103 - 3 · 103); and S. epidermidis, 3.3 ·
104 CFU (95% CI, 0 - 1.1 · 105; range, 6.75 · 104 -
9.75 · 104). The log10 values of the mean bacterial
counts are shown in Fig. 1.
Among the isolates of M. fortuitum and
M. chelonae, some isolates showed high values
for adherence (five M. fortuitum and four M. chelo-
nae isolates yielded total counts >350 · 103 CFU),
while other isolates yielded lower counts,
similar to those observed for M. peregrinum and
M. mucogenicum. One M. fortuitum isolate yielded
extremely low counts of adherent bacteria
(500 CFU) compared to all the other isolates of
the same species.
The multiple comparison of the mean total
bacterial counts among species did not indicate a
statistically significant difference (p 0.0577).
However, when paired data were analysed by
the Mann–Whitney test, significant differ-
ences were found between M. fortuitum and
M. peregrinum (p 0.017), and between M. chelonae
and M. peregrinum (p 0.033). The difference
between S. epidermidis and M. peregrinum almost
reached significance (p 0.055).
Twenty-six isolates produced colonies 0.5 mm
in diameter at day 4, and a further seven isolates
at day 5. The two remaining isolates required
6 days to reach the required colony size (Table 1).
Analysis of the growth rates showed no difference
between the isolates with high or low attachment
yields (Fisher’s exact test, p 0.2).
DISCUSSION
Infections caused by NPRGM, although infre-
quent, can be devastating in the hospital setting
[1,2,4], mainly because of the broad antimicrobial
resistance of these organisms. Furthermore, such
infections are associated mostly with biomaterials
and require aggressive therapy, but a favourable
outcome is unlikely in many cases of biomaterial-
related infections caused by NPRGM, e.g., pros-
thetic valve endocarditis [1,4]. The difficulty in
eradicating these organisms from a foreign body
is probably associated with their ability to form
biofilm [25].
Biofilm is a specialised mode of bacterial life
that can be found in many environmental and
clinical settings, including infections associated
with foreign bodies [26]. The initial step in
forming biofilm involves the adhesion of organ-
isms to the surface of the biomaterial. This is a
complex process that can be divided into two
steps [27,28]. First, bacteria attach non-specifically
to the surface as a result of, e.g., hydrophobicity,
electrostatic attraction and van der Waals forces.
Second, a more specific adherence occurs between
the bacteria and the substratum; this includes the
interaction of different structures and receptors
located on the bacteria and the substratum.
Although the relationship between NPRGM
and biomaterials has been known for decades
[29], only a few studies concerning the ability of
NPRGM to adhere to biomaterials have been
reported. Vess et al. [21] studied the ability of
several species of mycobacteria, including M. abs-
cessus and M. chelonae, to adhere to polyvinyl
chloride, and reported that both species were able
to colonise the inner surface of polyvinyl chloride
pipes and survive exposure to several disinfect-
ants. Ridgway et al. [30] analysed the adherence
of a Mycobacterium sp. to cellulose diacetate
membranes, but the precise species was not
identified. In addition, several studies have detec-
ted mycobacteria in biofilms [19,31–33], as well as
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the in-vitro development of biofilm by standard
strains of NPRGM [20,25,34]. Adherence ability,
as the first part of the process, is confirmed
implicitly by these studies.
Although the development of a biofilm was not
investigated in the present study, it is probable
that a biofilm could develop following the adher-
ence of the isolates to the biomaterial. Raad et al.
[8] detected biofilm caused by M. chelonae in an
intravenous catheter from a patient with catheter-
related bacteraemia, and several reports have
shown that NPRGM are able to grow in biofilms
in the most sterile hospital environments, includ-
ing disinfectant trays and disinfected instruments
[18,19,35].
The present study focused on polypropylene
monofilament sutures as the test material because
this biomaterial is used commonly in surgery, and
many nosocomial diseases caused by NPRGM are
related to surgical procedures and surgical site
infections [1,2,15,17,18,29,36]. Indeed, two cases of
NPRGM infections related to implantation of
polypropylene monofilament mesh in hernia sur-
gery have been diagnosed previously in the
Fundacio´n Jime´nez Dı´az hospital. In both of these
cases, removal of the prosthesis was required to
cure the patient. Mycobacteria were isolated in
large numbers from the mesh, indicating the
probable development of biofilm in both cases.
S. epidermidis, the bacterium isolated most fre-
quently from biomaterial-related infections,
served as a control in the present study.
The present study included several isolates of
the five most commonly described species of
NPRGM. The statistically significant differences
found could explain why the strongly adherent
M. fortuitum and M. chelonae are described fre-
quently as a cause of infections [1,2,4,29,36], while
the less adherent M. peregrinum is rarely consid-
ered to be clinically significant. The limited
number of isolates of other species tested means
that further studies are needed to evaluate these
species in more detail. No correlation was detec-
ted between growth rate and attachment, so
another explanation may exist for the differences
observed concerning attachment.
Although no specific adherence mechanism has
been studied for mycobacteria, lipid metabolism
has been implicated in the development of biofilm
[20,37,38] and other related bacterial properties,
e.g., sliding motility [39]. The mycobacterial cell
wall includes a high proportion of lipid molecules,
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Fig. 1. Numbers (log10) of bacteria attached to polypropylene sutures. Grey columns, values for individual strains; white
columns, mean value for each species.
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which makes these bacteria more hydrophobic
than other genera. Because hydrophobicity is an
important mechanism for attachment to biomate-
rials [27,28], it can be speculated that differences in
cell-wall lipids among strains or species of NPRGM
could explain the differences detected in the
present study. Other possible factors, e.g., the
influence of plasma or serum on attachment, were
not examined in the present study. Further studies
are also required to investigate the differences
found within individual species, e.g., M. fortuitum
and M. chelonae.
In conclusion, the species of NPRGM tested
were able to attach to polypropylene sutures.
Differences among and within species were
detected. The relationship between these findings
and the ability to cause human disease requires
further investigation.
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